Insider · CIK 0001864534
Javitt Daniel C.
Reports to the SEC for 1 company · WILMINGTON, DE
Transactions
13
Companies
1
Filings
8
CIK
0001864534
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-11-30 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$12.7K |
| 2022-11-29 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$20.7K |
| 2022-11-17 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$34.7K |
| 2022-11-16 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$136K |
| 2022-11-11 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$49.5K |
| 2022-07-29 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$791K |
| 2022-07-01 | NRXPNRX Pharmaceuticals, Inc.G Gift | — |
| 2022-06-07 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$55.9K |
| 2022-06-06 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$76.9K |
| 2022-06-03 | NRXPNRX Pharmaceuticals, Inc.S Sale | −$171K |
| 2021-07-16 | NRXPNRX Pharmaceuticals, Inc.G Gift | — |
| 2021-07-16 | NRXPNRX Pharmaceuticals, Inc.G Gift | — |
| 2021-05-24 | NRXPNRX Pharmaceuticals, Inc.A Award | — |
Recent filings
- 4Javitt Daniel C.0000880984-22-000017SEC(opens sec.gov)
- 4Javitt Daniel C.0000880984-22-000015SEC(opens sec.gov)
- 4Javitt Daniel C.0000880984-22-000014SEC(opens sec.gov)
- 4Javitt Daniel C.0000880984-22-000009SEC(opens sec.gov)
- 4Javitt Daniel C.0000880984-22-000008SEC(opens sec.gov)
- 4Javitt Daniel C.0000880984-22-000007SEC(opens sec.gov)
- 4Javitt Daniel C.0000950142-21-003505SEC(opens sec.gov)
- 4Javitt Daniel C.0000950142-21-001944SEC(opens sec.gov)
Companies
Address
C/O NRX PHARMACEUTICALS, INC. 1201 ORANGE STREET, SUITE 600
WILMINGTON, DE, 19801